First-year results of the Global Influenza Hospital Surveillance Network: 2012–2013 Northern hemisphere influenza season

BMC Public Health

Cedric Mahé³  Sergio Martínez-Úbeda⁴  Amparo Buigues-Vila⁴  Angels Natividad-Sancho⁴  Meral A Ciblak⁶  Odile Launay⁵  Elena Burtseva¹  Anna Sominina²  Anita Tormos⁴  Joan Puig-Barberà⁴ 

[1] D.I. Ivanovsky Institute of Virology, Moscow, Russian Federation;Research Institute of Influenza, St. Petersburg, Russian Federation;Sanofi Pasteur, Lyon, France;Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunidad Valenciana (FISABIO-Salud Pública), Valencia, Spain;Université Paris Descartes, Sorbonne Paris Cité and Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Paris, France;National Influenza Reference Laboratory, Istanbul, Turkey

关键词: Hospital;    Surveillance network;    Influenza epidemiology;   

Others  :  1129754
DOI  :  10.1186/1471-2458-14-564

 received in 2014-04-01, accepted in 2014-05-28,  发布年份 2014

【 摘 要 】

Background

The Global Influenza Hospital Surveillance Network (GIHSN) was developed to improve understanding of severe influenza infection, as represented by hospitalized cases. The GIHSN is composed of coordinating sites, mainly affiliated with health authorities, each of which supervises and compiles data from one to seven hospitals. This report describes the distribution of influenza viruses A(H1N1), A(H3N2), B/Victoria, and B/Yamagata resulting in hospitalization during 2012–2013, the network’s first year.

Methods

In 2012–2013, the GIHSN included 21 hospitals (five in Spain, five in France, four in the Russian Federation, and seven in Turkey). All hospitals used a reference protocol and core questionnaire to collect data, and data were consolidated at five coordinating sites. Influenza infection was confirmed by reverse-transcription polymerase chain reaction. Hospitalized patients admitted within 7 days of onset of influenza-like illness were included in the analysis.

Results

Of 5034 patients included with polymerase chain reaction results, 1545 (30.7%) were positive for influenza. Influenza A(H1N1), A(H3N2), and both B lineages co-circulated, although distributions varied greatly between coordinating sites and over time. All age groups were affected. A(H1N1) was the most common influenza strain isolated among hospitalized adults 18–64 years of age at four of five coordinating sites, whereas A(H3N2) and B viruses were isolated more often than A(H1N1) in adults ≥65 years of age at all five coordinating sites. A total of 16 deaths and 20 intensive care unit admissions were recorded among patients with influenza.

Conclusions

Influenza strains resulting in hospitalization varied greatly between coordinating sites and over time. These first-year results of the GIHSN are relevant, useful, and timely. Due to its broad regional representativeness and sustainable framework, this growing network should contribute substantially to understanding the epidemiology of influenza, particularly for more severe disease.

【 授权许可】

   
2014 Puig-Barberà et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Influenza (Seasonal), factsheet 211 http://www.who.int/mediacentre/factsheets/fs211/en/ webcite
• [2]Paget J, Marquet R, Meijer A, van der Velden K: Influenza activity in Europe during eight seasons (1999–2007): an evaluation of the indicators used to measure activity and an assessment of the timing, length and course of peak activity (spread) across Europe. BMC Infect Dis 2007, 7:141. BioMed Central Full Text
• [3]Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ, Fukuda K: Influenza-associated hospitalizations in the United States. JAMA 2004, 292(11):1333-1340.
• [4]Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, Fukuda K: Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003, 289(2):179-186.
• [5]Brammer L, Budd A, Cox N: Seasonal and pandemic influenza surveillance considerations for constructing multicomponent systems. Influenza Other Respir Viruses 2009, 3(2):51-58.
• [6]Ortiz JR, Sotomayor V, Uez OC, Oliva O, Bettels D, McCarron M, Bresee JS, Mounts AW: Strategy to enhance influenza surveillance worldwide. Emerg Infect Dis 2009, 15(8):1271-1278.
• [7]World Health Organization: WHO Interim Global Epidemiological Surveillance Standards for Influenza. 2012.
• [8]Kelly HA, Sullivan SG, Grant KA, Fielding JE: Moderate influenza vaccine effectiveness with variable effectiveness by match between circulating and vaccine strains in Australian adults aged 20–64 years, 2007–2011. Influenza Other Respir Viruses 2013, 7(5):729-737.
• [9]Ohmit SE, Petrie JG, Malosh RE, Cowling BJ, Thompson MG, Shay DK, Monto AS: Influenza vaccine effectiveness in the community and the household. Clin Infect Dis 2013, 56(10):1363-1369.
• [10]Public health Agency of Canadian Institutes of Health Research Influenza Research Network (PCIRN): PHAC/CIHR Influenza Research Network 2013 Annual Report. 2013.
• [11]Skowronski DM, De Serres G, Dickinson J, Petric M, Mak A, Fonseca K, Kwindt TL, Chan T, Bastien N, Charest H, Li Y: Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006–2007. J Infect Dis 2009, 199(2):168-179.
• [12]Valenciano M, Ciancio B, team IMs: I-MOVE: a European network to measure the effectiveness of influenza vaccines. Euro Surveill 2012, 17:39.
• [13]Michiels B, Govaerts F, Remmen R, Vermeire E, Coenen S: A systematic review of the evidence on the effectiveness and risks of inactivated influenza vaccines in different target groups. Vaccine 2011, 29(49):9159-9170.
• [14]Baker M, Kelly H, Wilson N: Pandemic H1N1 influenza lessons from the southern hemisphere. Euro Surveill 2009, 14:42.
• [15]Beaute J, Broberg E, Plata F, Bonmarin I, OD J, Delgado C, Boddington N, Snacken R: Overrepresentation of influenza A(H1N1)pdm09 virus among severe influenza cases in the 2011/12 season in four European countries. Euro Surveill 2012, 17:9.
• [16]Poehling KA, Edwards KM, Griffin MR, Szilagyi PG, Staat MA, Iwane MK, Snively BM, Suerken CK, Hall CB, Weinberg GA, Chaves SS, Zhu Y, McNeal MM, Bridges CB: The burden of influenza in young children, 2004–2009. Pediatrics 2013, 131(2):207-216.
• [17]Williamson DA, Huang QS, Roberts SA, Grant CC, McArthur C, Baker MG: Surveillance for influenza using hospital discharge data may underestimate the burden of influenza-related hospitalization. Infect Control Hosp Epidemiol 2012, 33(10):1064-1066.
• [18]Influenza case definitions http://www.ecdc.europa.eu/en/activities/surveillance/eisn/surveillance/pages/influenza_case_definitions.aspx webcite
• [19]Fiore AE, Uyeki TM, Broder K, Finelli L, Euler GL, Singleton JA, Iskander JK, Wortley PM, Shay DK, Bresee JS, Cox NJ, Centres for Disease Control and Prevention (CDC): Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 2010, 59(RR-8):1-62.
• [20]Foppa IM, Haber M, Ferdinands JM, Shay DK: The case test-negative design for studies of the effectiveness of influenza vaccine. Vaccine 2013, 31(30):3104-3109.
• [21]Healthy People 2020 summary of objectives http://healthypeople.gov/2020/topicsobjectives2020/pdfs/Immunization.pdf webcite
• [22]Strategic Advisory Group of Experts (SAGE) on Immunization http://www.who.int/immunization/sage/en/ webcite
• [23]Paul Glezen W, Schmier JK, Kuehn CM, Ryan KJ, Oxford J: The burden of influenza B: a structured literature review. Am J Public Health 2013, 103(3):e43-e51.
• [24]Vaccine European New Integrated Collaboration Effort: Seasonal influenza vaccination survey in EU/EEA, influenza season 2009–10. 2011.
• [25]Tuppin P, Choukroun S, Samson S, Weill A, Ricordeau P, Allemand H: [Vaccination against seasonal influenza in France in 2010 and 2011: decrease of coverage rates and associated factors]. Presse Med 2012, 41(11):e568-e576.
• [26]Osterholm MT, Kelley NS, Sommer A, Belongia EA: Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012, 12(1):36-44.